As of Jul 21
| +0.04 / +1.61%|
The 3 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 9.00, with a high estimate of 9.00 and a low estimate of 8.00. The median estimate represents a +257.14% increase from the last price of 2.52.
The current consensus among 3 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.